271587-45-2

Basic information

• Product Name: 1,2-Pentanediol, 4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)-
• CAS NO: 271587-45-2
• Molecular Formula: C14H18F4O3
• Molecular Weight: 310.289
• Mol File: 271587-45-2.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: 1,2-Pentanediol, 4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Pentanediol, 4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)-(271587-45-2)
• EPA Substance Registry System: 1,2-Pentanediol, 4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)-(271587-45-2)

Safety Data

• Hazardous Substances Data: 271587-45-2(Hazardous Substances Data)

Upstream product

• 459-60-9 1-fluoro-4-methoxybenzene 
• 217195-91-0 ethyl 2-hydroxy-4-methyl-2-(trifluoromethyl)-4-pentenoate 
• 217195-92-1 4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentanoic acid ethyl ester 

Downstream Products

• 609806-82-8 1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-one 
• 609806-92-0 3-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile 
• 609807-13-8 4-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzaldehyde 
• 217196-41-3 4-toluenesulfonic acid-[2-hydroxy-4-(2-methoxy-5-fluorophenyl)-4-methyl-2-trifluoromethyl-pentyl]-ester 
• 611231-08-4 rac-4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanal 
• 271587-47-4 2-[2-(5-fluoro-2-methoxyphenyl)-2-methylpropyl]-2-(trifluoromethyl)oxirane 

Relevant articles and documents

NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF

The present invention relates to the two enantiomers of a SElective Glucocorticoid Receptor Agonistic Modulator (SEGRAM) of Formula 1 or a derivative thereof; to a deuterated form of a SEGRAM of Formula 1 or a derivative thereof; and to the two deuterated

Identification of dissociated non-steroidal glucocorticoid receptor agonists

A new series of ligands for the glucocorticoid receptor (GR) is described. SAR development was guided by docking 3 into the GR active site and optimizing an unsubstituted phenyl ring for key interactions found in the steroid A-ring binding pocket. To iden

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

A compound of Formula (IA) or Formula (IB) wherein R1, R2, R3, R4, R5, R6, R7,and R8 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceu